Medicare Negotiation and Competitive Licensing Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 29, 2021)
Medicare Negotiation and Competitive Licensing Act of 2021
This bill establishes several requirements relating to the prices of prescription drugs.
Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under Medicare. (Current law prohibits the CMS from doing so.) If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under health insurance programs, notwithstanding existing government-granted exclusivities.
The negotiated prices also apply to other federal health care programs, private health insurance, and the uninsured; pharmacies that charge more than the negotiated price for uninsured individuals are subject to civil penalties. Manufacturers must also comply with specified reporting requirements relating to prices and licensing, subject to civil penalties.
The bill also institutes an excise tax on drugs for which the price spikes beyond a certain limit, subject to specified exemptions, as well as on drugs for which the price exceeds the negotiated price.
What just happenedSep 8, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 29, 2021
- Sep 8, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 30, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 29, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Armed Services Committee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Veterans' Affairs Committee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oversight and Accountability Committee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 29, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 29, 2021IntroReferralIntro-H
Introduced in House
- Jul 29, 2021IntroReferral1000
Introduced in House